Reviewed by Varnada Karriem-Norwood on May 27, 2012
Nancy Kemeny, MD. Oncologist; Colorectal Cancer Specialist Memorial Sloan-Kettering Cancer Center Professor of MedicineWeill Medical College of Cornell University
© 2008 WebMD, LLC. All rights reserved.
Nancy Kemeny, MD: In the past, it was not useful to remove more than 3 metastases, that you would not have a long range survival. It was bad, and now with what we're doing, with resection, working with the surgeons, we're taking the tumors out. 30% live 5 years. We never had anybody alive 5 years before. So 30% live 5 years if we can get the tumor out, and now with the new work that we're doing with the hepatic arterial therapy, which means that we're putting the chemotherapy directly into the liver, we have 56% alive at 5 years, and 40% at 10 years. So we have patients with liver metastasis where you know they used to be dead in 8 months, now alive for 10 years, so we've really made progress there.